Asset Dedication LLC’s Biogen BIIB Stock Holding History

Asset Dedication LLC’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.91K	Sell	32 -26	-45%	-$4.97K	﹤0.01%	848
2026 Q1	$10.6K	Buy	58 +1	+2%	+$184	﹤0.01%	758
2025 Q4	$10K	Hold	57	–	–	﹤0.01%	779
2025 Q3	$7.99K	Sell	57 -17	-23%	-$2.3K	﹤0.01%	836
2025 Q2	$9.29K	Sell	74 -30	-29%	-$3.74K	﹤0.01%	831
2025 Q1	$14.2K	Hold	104	–	–	﹤0.01%	708
2024 Q4	$15.9K	Sell	104 -40	-28%	-$6.75K	﹤0.01%	696
2024 Q3	$27.9K	Sell	144 -13	-8%	-$2.72K	﹤0.01%	614
2024 Q2	$36.4K	Sell	157 -53	-25%	-$11.5K	﹤0.01%	545
2024 Q1	$46K	Hold	210	–	–	﹤0.01%	456
2023 Q4	$54K	Hold	210	–	–	﹤0.01%	418
2023 Q3	$54K	Sell	210 -13	-6%	-$3.48K	﹤0.01%	416
2023 Q2	$65K	Hold	223	–	–	0.01%	408
2023 Q1	$63K	Hold	223	–	–	0.01%	408
2022 Q4	$63K	Sell	223 -7	-3%	-$1.98K	0.01%	400
2022 Q3	$60K	Sell	230 -14	-6%	-$2.97K	0.01%	391
2022 Q2	$50K	Sell	244 -20	-8%	-$4.09K	0.01%	228
2022 Q1	$55K	Sell	264 -7	-3%	-$1.52K	0.01%	411
2021 Q4	$65K	Sell	271 -76	-22%	-$19.5K	0.01%	371
2021 Q3	$101K	Hold	347	–	–	0.01%	316
2021 Q2	$122K	Hold	347	–	–	0.02%	296
2021 Q1	$99K	Sell	347 -6	-2%	-$1.62K	0.02%	273
2020 Q4	$84K	Sell	353 -369	-51%	-$95.2K	0.02%	310
2020 Q3	$208K	Buy	722 +19	+3%	+$5.3K	0.05%	218
2020 Q2	$186K	Sell	703 -605	-46%	-$182K	0.05%	203
2020 Q1	$413K	Buy	1,308 +910	+229%	+$276K	0.12%	144
2019 Q4	$119K	Buy	398 +6	+2%	+$1.67K	0.03%	220
2019 Q3	$92K	Sell	392 -21	-5%	-$4.89K	0.03%	231
2019 Q2	$99K	Hold	413	–	–	0.03%	222
2019 Q1	$100K	Hold	413	–	–	0.03%	212
2018 Q4	$124K	Sell	413 -14	-3%	-$4.47K	0.05%	181
2018 Q3	$149K	Hold	427	–	–	0.06%	169
2018 Q2	$125K	Hold	427	–	–	0.04%	185
2018 Q1	$118K	Hold	427	–	–	0.06%	164
2017 Q4	$133K	Sell	427 -30	-7%	-$9.62K	0.05%	164
2017 Q3	$142K	Hold	457	–	–	0.07%	146
2017 Q2	$126K	Sell	457 -86	-16%	-$22.7K	0.06%	155
2017 Q1	$149K	Sell	543 -7	-1%	-$1.98K	0.08%	141
2016 Q4	$160K	Sell	550 -685	-55%	-$203K	0.09%	139
2016 Q3	$386K	Buy	1,235 +158	+15%	+$46.8K	0.24%	102
2016 Q2	$264K	Sell	1,077 -151	-12%	-$39.8K	0.18%	107
2016 Q1	$320K	Buy	1,228 +3	+0.2%	+$792	0.24%	95
2015 Q4	$375K	Buy	+1,225	New	+$352K	0.25%	97

Other funds holding BIIB

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Asset Dedication LLC's BIIB Position: Q2 2026 in Review

Asset Dedication LLC reduced its Biogen (BIIB) stake by 45% in Q2 2026, selling an estimated $4.97K and leaving 32 shares worth $6.91K. The position accounts for ﹤0.01% of the portfolio, ranked #848.

Asset Dedication LLC first reported a position in BIIB in Q4 2015 and has held it in 43 quarters since. The position peaked at $413K in Q1 2020. 403 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Asset Dedication LLC held 32 shares of Biogen worth $6.91K as of Q2 2026.
Asset Dedication LLC sold 26 Biogen shares in Q2 2026, an estimated $4.97K.
Biogen made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #848 holding.
Asset Dedication LLC first reported a position in Biogen in Q4 2015 and has held it in 43 quarters since.
Asset Dedication LLC's Biogen position peaked at $413K in Q1 2020.
403 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.